临床试验Nct页
Clinical Trial Results:
Phase II Multiple-Dose Clinical Trial of Oral ITF 2357 In Patients with Advanced Multiple Myeloma
| Summary | |
EudraCT number | 2005-001084-56 |
Trial protocol | IT |
Global completion date | 30 Jun 2007 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v2(current) |
This version publication date | 31 Jul 2019 |
First version publication date | 14 Jun 2019 |
Other versions | v1 |
Version creation reason |
|
Summary report(s) | 2005-001084-56 Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.